This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa
The drug BETMIGA contains one active pharmaceutical ingredient (API):
1
Mirabegron
UNII MVR3JL3B2V - MIRABEGRON
|
Mirabegron is a potent and selective beta3-adrenoceptor agonist. Mirabegron enhances urine storage function by stimulating beta3-adrenoceptors in the bladder. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
BETMIGA Prolonged-release tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
G04BD12 | G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 11676019, 11676031 |
Country: EE | Ravimiamet | Identifier(s): 1604179, 1604269, 1604270, 1604281, 1604292, 1604304, 1604315, 1604326, 1604337, 1604348, 1604359, 1604360, 1645286, 1645297, 1645309, 1645310 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 112809010 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 093284, 409927, 501278, 595198 |
Country: FR | Base de données publique des médicaments | Identifier(s): 61782473, 66383994 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 219732, 219735, 379799, 379801, 381198 |
Country: HK | Department of Health Drug Office | Identifier(s): 62460, 62461 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 17598, 17632, 17633 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 7534, 7535 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1069203, 1069204, 1069205, 1069206, 1069207, 1069208, 1069209, 1069210, 1069211, 1069212, 1069213, 1069214, 1069215, 1069216, 1072975, 1072976, 1072977, 1072978 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 112305 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100295334, 100295357 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W59965001, W59965002, W59965003, W59965004, W59965005, W59965006, W59965007, W59966001, W59966002, W59966003, W59966004, W59966005, W59966006, W59966007 |
Country: SG | Health Sciences Authority | Identifier(s): 14622P, 14623P |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699043890024, 8699043890031, 8699043890055, 8699043890062, 8699043890079, 8699043890086, 8699043890093, 8699043890109, 8699043890116, 8699043890123, 8699043890130, 8699043890147, 8699043890154, 8699043890161 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 47/16.5/0297, 47/16.5/0298 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.